About TOLERANCE BIO, INC.
Tolerance Bio is a biotechnology company focused on increasing healthspan by preserving, restoring, and manipulating the function of the thymus, the master regulator of immune tolerance. The company is developing novel, multi-platform approaches to control immune tolerance for the treatment of immune-mediated diseases.
Development of thymic organoids from human pluripotent stem cellsGeneration of functional human thymic cells from induced pluripotent stem cellsResearch in immune tolerance and its role in diseases such as cancer, autoimmunity, transplant rejection, infections, immune deficiencies, and allergy
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to TOLERANCE BIO, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.